Skip to main content
TipRanks
Go Ultimate75% OFF

InfuSystem Holdings (INFU) Revenue by Segment

355 Followers

Revenue by Segment

In Q3 2026, InfuSystem Holdings reported revenue by segment of $25.81M (Patient Services) and $13.37M (Device Solutions).

Breaks down sales across the company’s different business units, showing where growth is coming from and how concentrated the revenue base is. For InfuSystem, a shift toward recurring service and rental revenue improves predictability, while dependence on a few products or customers raises exposure to reimbursement and procurement cycles.

$0.00$10.00M$20.00M$30.00M$40.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Patient Services is the steady growth engine—buoyed by Oncology and rapidly scaling Wound Care—while Device Solutions shows pronounced volatility driven by equipment‑sale swings and the GE contract restructuring. That restructuring is a near‑term revenue headwind but margin‑accretive, helping consolidated gross margins and adjusted EBITDA. The company’s ability to hit its pro‑forma growth and mid‑20s EBITDA target depends on stabilizing Device Solutions equipment sales and restoring Patient Services margins (currently pressured by mix, maintenance costs and ERP transition); those are the key catalysts and risks to watch.

INFU Revenue by Segment

PeriodPatient ServicesDevice Solutions
Q3 2026Sep 30, 2026$25.81M$13.37M
Q2 2026Jun 30, 2026$24.79M$13.96M
Q1 2026Mar 31, 2026$22.11M$11.58M
Q4 2025Dec 31, 2025$21.88M$15.95M
Q3 2025Sep 30, 2025$22.36M$16.07M
Q2 2025Jun 30, 2025$21.52M$16.25M
Q1 2025Mar 31, 2025$20.77M$15.82M
Q4 2024Dec 31, 2024$20.76M$14.89M
Q3 2024Sep 30, 2024$20.78M$16.53M
Q2 2024Jun 30, 2024$20.25M$15.19M
Q1 2024Mar 31, 2024$18.59M$15.12M
Q4 2023Dec 31, 2023$19.16M$14.28M
Q3 2023Sep 30, 2023$19.29M$14.22M
Q2 2023Jun 30, 2023$19.32M$14.10M
Q1 2023Mar 31, 2023$18.77M$13.23M
Q4 2022Dec 31, 2022$17.62M$12.82M
Q3 2022Sep 30, 2022$17.38M$11.51M
Q2 2022Jun 30, 2022$17.24M$11.56M
Q1 2022Mar 31, 2022$16.64M$11.61M
Q4 2021Dec 31, 2021$16.77M$11.02M
Q3 2021Sep 30, 2021$16.58M$11.43M
Q2 2021Jun 30, 2021$16.33M$10.10M
Q1 2021Mar 31, 2021$15.91M$10.00M
Q4 2020Dec 31, 2020$15.70M$10.42M
Q3 2020Sep 30, 2020$15.64M$10.95M
Q2 2020Jun 30, 2020$15.61M$11.65M
Q1 2020Mar 31, 2020$14.13M$8.66M

Related KPIs